- Home
- IOTR vs ACRV Comparison
IOTR vs ACRV Comparison
Compare IOTR & ACRV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IOTR
- ACRV
- Stock Information
- Founded
- IOTR 2019
- ACRV 2018
- Country
- IOTR Singapore
- ACRV United States
- Employees
- IOTR N/A
- ACRV N/A
- Industry
- IOTR
- ACRV Medicinal Chemicals and Botanical Products
- Sector
- IOTR
- ACRV Health Care
- Exchange
- IOTR NYSE
- ACRV Nasdaq
- Market Cap
- IOTR 29.5M
- ACRV 34.5M
- IPO Year
- IOTR 2025
- ACRV 2022
- Fundamental
- Price
- IOTR $0.41
- ACRV $1.35
- Analyst Decision
- IOTR
- ACRV Buy
- Analyst Count
- IOTR 0
- ACRV 7
- Target Price
- IOTR N/A
- ACRV $17.60
- AVG Volume (30 Days)
- IOTR 671.5K
- ACRV 758.0K
- Earning Date
- IOTR 01-01-0001
- ACRV 05-14-2025
- Dividend Yield
- IOTR N/A
- ACRV N/A
- EPS Growth
- IOTR N/A
- ACRV N/A
- EPS
- IOTR N/A
- ACRV N/A
- Revenue
- IOTR $9,578,336.00
- ACRV N/A
- Revenue This Year
- IOTR N/A
- ACRV N/A
- Revenue Next Year
- IOTR N/A
- ACRV N/A
- P/E Ratio
- IOTR N/A
- ACRV N/A
- Revenue Growth
- IOTR 13.93
- ACRV N/A
- 52 Week Low
- IOTR $0.31
- ACRV $1.05
- 52 Week High
- IOTR $5.98
- ACRV $10.16
- Technical
- Relative Strength Index (RSI)
- IOTR N/A
- ACRV 50.04
- Support Level
- IOTR N/A
- ACRV $1.06
- Resistance Level
- IOTR N/A
- ACRV $1.19
- Average True Range (ATR)
- IOTR 0.00
- ACRV 0.09
- MACD
- IOTR 0.00
- ACRV 0.07
- Stochastic Oscillator
- IOTR 0.00
- ACRV 93.75
About ACRV Acrivon Therapeutics Inc.
Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes the Phase 2 lead program, ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1, a closely related protein serine/threonine kinase.